Skip to content

Troleandomycin

Published: July 26, 2026Updated: August 25, 2026

Troleandomycin is a macrolide antibiotic used to treat various bacterial infections by inhibiting bacterial protein synthesis. It is primarily indicated for respiratory tract infections, skin infections, and other conditions caused by susceptible organisms. This medication is reserved for situations where first-line antibiotics are not appropriate or have proven ineffective.

Quick summary

Troleandomycin is a macrolide antibiotic used to treat bacterial infections when other antibiotics are not suitable.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ATC
J01FA08
RxNorm
10864
Generic
Troleandomycin
Class
atc-j01
Brands
—
Availability
rx
Lactation
unknown
Routes
oral
Forms
capsule
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Treatment of respiratory tract infections (such as pneumonia and bronchitis), skin and soft tissue infections, and other infections caused by susceptible bacteria including certain strains of Staphylococcus, Streptococcus, and Haemophilus species. May also be used for pertussis and diphtheria in certain cases.

Troleandomycin is a macrolide antibiotic that works by binding to the bacterial ribosome (specifically the 50S subunit), inhibiting bacterial protein synthesis. This bacteriostatic action prevents the growth and replication of susceptible bacteria, allowing the body's immune system to eliminate the infection.

Use with caution in patients with liver disease or hepatic impairment due to potential hepatotoxicity. May cause gastrointestinal side effects such as nausea, vomiting, and diarrhea. Drug interactions are possible, particularly with medications metabolized by CYP450 enzymes. Contraindicated in patients with known hypersensitivity to macrolide antibiotics. Not typically used as first-line therapy due to its side effect profile compared to other antibiotics.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy